Burjeel Holdings has received its first corporate credit ratings from two of the world’s leading agencies and launched a USD 1.5 billion Sukuk Programme, significantly strengthening the Abu Dhabi-listed healthcare group’s capacity to fund its long-term clinical and digital expansion.

S&P Global Ratings assigned a BB+ issuer credit rating with a Stable outlook, while Moody’s awarded a Ba2 corporate family rating, also Stable. Both agencies pointed to Burjeel’s strong market position across the UAE and wider GCC, sound financial governance, and the resilient demand fundamentals of the regional healthcare sector as central to their assessments.

Click here to join our WhatsApp channel here

The Sukuk Programme, established through special purpose vehicle Burjeel Sukuk Limited and admitted to the London Stock Exchange’s International Securities Market, provides a Shariah-compliant platform to access debt capital markets. Proceeds are directed toward advanced clinical care, medical research and education, digital transformation, and AI-enabled healthcare innovation, priorities that reflect the group’s ambition to operate at the leading edge of specialty care delivery.

Burjeel’s network spans primary through quaternary care across the UAE, Saudi Arabia, and Oman, underpinned by structural tailwinds including population growth, expanding mandatory health insurance, rising demand for specialised treatment, and the GCC’s growing medical tourism sector.

Also read: Bundibugyo virus outbreak surpasses 900 cases in DRC and Uganda

Chairman and CEO Dr. Shamsheer Vayalil said “the milestone reflects the strength of the group’s platform and its commitment to financial discipline, framing the Sukuk Programme as a vehicle to pursue healthcare innovation while supporting the UAE’s broader ambition to become a global centre for medical excellence.”

Burjeel has also begun investor meetings regarding a potential inaugural five-year USD benchmark Sukuk issuance, subject to market conditions.